Detalhe da pesquisa
1.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Nature
; 580(7804): 517-523, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32322066
2.
Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Nat Genet
; 52(7): 662-668, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424350
3.
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Nat Genet
; 52(7): 748-749, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587373
4.
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits ß-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.
Mol Cancer Ther
; 18(11): 1916-1925, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488700